Baudax Bio, Inc. Intellectual Property Contracts & Agreements

6 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Biological Materials License Agreement, dated August 26, 2019, by and between the U.S. Department of Health and Human Services, as represented by the National Cancer Institute and...
License Agreements
Baudax Bio, Inc.
Pharmaceuticals
2023
Exclusive License Agreement, dated August 5, 2019, by and between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. and TeraImmune, Inc
License Agreements
Baudax Bio, Inc.
Pharmaceuticals
MD
2023
Exclusive License Agreement, dated November 11, 2020, by and between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. and TeraImmune, Inc
License Agreements
Baudax Bio, Inc.
Pharmaceuticals
MD
2023
Exclusive Patent License Agreement, dated as of June 18, 2020, by and between the U.S. Department of Health and Human Services, as represented by the National Institute of Allergy...
License Agreements
Baudax Bio, Inc.
Pharmaceuticals
2023
Third Amendment to License Agreement, dated August 17, 2020, by and among Alkermes Pharma Ireland Limited, Recro Gainesville LLC and Baudax Bio, Inc
License Agreements
Baudax Bio, Inc.
Pharmaceuticals
DE
2020
Amendment to License Agreement, dated October 21, 2019, by and between Cornell University and Recro Pharma, Inc
License Agreements
Baudax Bio, Inc.
Pharmaceuticals
2020